Skip to main content

Advertisement

Log in

Membrane lipid rafts and estrogenic signalling: a functional role in the modulation of cell homeostasis

  • THE ROLE OF SPHINGOLIPIDS AND LIPID RAFTS IN DETERMINING CELL FATE
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

It has become widely accepted that along with their ability to directly regulate gene expression, estrogens also influence cell signalling and cell function via rapid membrane-initiated events. Many of these signalling processes are dependent on estrogen receptors (ER) localized to the plasma membrane. However, the mechanisms by which ER are able to trigger cell signalling when targeted to the membrane surface have to be determined yet. Lipid rafts seem to be essential for the plasma membrane localization of ER and play a critical role in their membrane-initiated effects. In this review, we briefly recapitulate the localization and function of ER in different cell types and mostly discuss the possible role of lipid rafts in this context. Further studies in this field may disclose new promising therapeutic avenues by the disruption of lipid rafts in those diseases in which membrane ER activation has been demonstrated to play a pathogenetic role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ascenzi P, Bocedi A, Marino M (2006) Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 27:299–402

    Article  CAS  PubMed  Google Scholar 

  2. Mangelsdorf DJ, Thummel C, Beato M et al (1995) The nuclear receptor superfamily: the second decade. Cell 83:835–839

    Article  CAS  PubMed  Google Scholar 

  3. Bottner M, Thelen P, Jarry H (2014) Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function. J Steroid Biochem Mol Biol 139:245–251

    Article  CAS  PubMed  Google Scholar 

  4. Heldring N, Pike A, Andersson S et al (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905–931

    Article  CAS  PubMed  Google Scholar 

  5. Levin ER (2009) Plasma membrane estrogen receptors. Trends Endocrinol Metab 20:477–482

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Mendelsohn ME, Karas RH (2010) Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest 120:2277–2279

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Pappas TC, Gametchu B, Watson CS (1995) Membrane estrogen receptor-enriched GH(3)/B6 cells have an enhanced non-genomic response to estrogen. Endocrine 3:743–749

    Article  CAS  PubMed  Google Scholar 

  8. Pietras RJ, Szego CM (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265:69–72

    Article  CAS  PubMed  Google Scholar 

  9. George KS, Wu S (2012) Lipid raft: a floating island of death or survival. Toxicol Appl Pharmacol 259:311–319

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Marin R, Marrero-Alonso J, Fernandez C, Cury D, Diaz M (2012) Estrogen receptors in lipid raft signalling complexes for neuroprotection. Front Biosci (Elite Ed) 4:1420–1433

    Article  Google Scholar 

  11. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569–572

    Article  CAS  PubMed  Google Scholar 

  12. Fabelo N, Martin V, Gonzalez C, Alonso A, Diaz M (2012) Effects of oestradiol on brain lipid class and Fatty Acid composition: comparison between pregnant and ovariectomised oestradiol-treated rats. J Neuroendocrinol 24:292–309

    Article  CAS  PubMed  Google Scholar 

  13. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER (2007) A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282:22278–22288

    Article  CAS  PubMed  Google Scholar 

  14. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER (2003) Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23:1633–1646

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Williams TM, Lisanti MP (2004) The caveolin proteins. Genome Biol 5:214

    Article  PubMed Central  PubMed  Google Scholar 

  16. Michel V, Bakovic M (2007) Lipid rafts in health and disease. Biol Cell 99:129–140

    Article  CAS  PubMed  Google Scholar 

  17. Mukherjee R, Kim SW, Choi MS, Yun JW (2014) Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats. PLoS One 9(3):e90918

    Article  PubMed Central  PubMed  Google Scholar 

  18. Sun M, Paciga JE, Feldman RI et al (2001) Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res 61:5985–5991

    CAS  PubMed  Google Scholar 

  19. Bulayeva NN, Gametchu B, Watson CS (2004) Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69:181–192

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Zhang D, Trudeau VL (2006) Integration of membrane and nuclear estrogen receptor signaling. Comp Biochem Physiol A 144:306–315

    Article  Google Scholar 

  21. Acconcia F, Totta P, Ogawa S et al (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 203:193–201

    Article  CAS  PubMed  Google Scholar 

  22. Aguirre JI, Plotkin LI, Gortazar AR, Millan MM, O’Brien CA, Manolagas SC, Bellido T (2007) A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J Biol Chem 282:25501–25508

    Article  CAS  PubMed  Google Scholar 

  23. Guo X, Razandi M, Pedram A, Kassab G, Levin ER (2005) Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 280:19704–19710

    Article  CAS  PubMed  Google Scholar 

  24. Chambliss KL, Shaul PW (2002) Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23:665–686

    Article  CAS  PubMed  Google Scholar 

  25. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW (2002) ERbeta has nongenomic action in caveolae. Mol Endocrinol 16:938–946

    CAS  PubMed  Google Scholar 

  26. Razandi M, Pedram A, Levin ER (2000) Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 275:38540–38546

    Article  CAS  PubMed  Google Scholar 

  27. Kiss AL, Turi A, Mullner N, Kovacs E, Botos E, Greger A (2005) Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study. Mol Cell Endocrinol 245:128–137

    Article  CAS  PubMed  Google Scholar 

  28. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER (2002) ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100–115

    Article  CAS  PubMed  Google Scholar 

  29. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22:2185–2197

    Article  CAS  PubMed  Google Scholar 

  30. Ishikawa T, Yuhanna IS, Umetani J et al (2013) LXRbeta/estrogen receptor-alpha signaling in lipid rafts preserves endothelial integrity. J Clin Invest 123:3488–3497

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Repa JJ, Mangelsdorf DJ (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8:1243–1248

    Article  CAS  PubMed  Google Scholar 

  32. Tontonoz P, Mangelsdorf DJ (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17:985–993

    Article  CAS  PubMed  Google Scholar 

  33. Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Lu TT, Repa JJ, Mangelsdorf DJ (2001) Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276:37735–37738

    Article  CAS  PubMed  Google Scholar 

  35. Ueda K, Karas RH (2013) Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system. Steroids 78:589–596

    Article  CAS  PubMed  Google Scholar 

  36. Ortmann J, Veit M, Zingg S et al (2011) Estrogen receptor-alpha but not -beta or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab 96:220–228

    Article  PubMed Central  PubMed  Google Scholar 

  37. Takeda-Matsubara Y, Nakagami H, Iwai M et al (2002) Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 39:41–45

    Article  CAS  PubMed  Google Scholar 

  38. Lu Q, Surks HK, Ebling H et al (2003) Regulation of estrogen receptor alpha-mediated transcription by a direct interaction with protein phosphatase 2A. J Biol Chem 278:4639–4645

    Article  CAS  PubMed  Google Scholar 

  39. Yang L, Wang Y, Chen P et al (2011) Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Endocrinology 152:4537–4549

    Article  CAS  PubMed  Google Scholar 

  40. Ortona E, Gambardella L, Barbati C, Malorni W (2014) Membrane-associated functional estrogen receptors alpha are upregulated in cardiomyocytes under oxidative imbalance. IJC Metab Endocr 5:67–69

    Article  Google Scholar 

  41. Chung TH, Wang SM, Liang JY, Yang SH, Wu JC (2009) The interaction of estrogen receptor alpha and caveolin-3 regulates connexin43 phosphorylation in metabolic inhibition-treated rat cardiomyocytes. Int J Biochem Cell Biol 41:2323–2333

    Article  CAS  PubMed  Google Scholar 

  42. Patel HH, Head BP, Petersen HN et al (2006) Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol 291:H344–H350

    Article  CAS  PubMed  Google Scholar 

  43. Horikawa YT, Patel HH, Tsutsumi YM et al (2008) Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 44:123–130

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Ratajczak P, Damy T, Heymes C et al (2003) Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc Res 57:358–369

    Article  CAS  PubMed  Google Scholar 

  45. Elkeles RS, Hampton JR, Mitchell JR (1968) Effect of oestrogens on human platelet behaviour. Lancet 2:315–318

    Article  CAS  PubMed  Google Scholar 

  46. Bar J, Lahav J, Hod M, Ben-Rafael Z, Weinberger I, Brosens J (2000) Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost 84:695–700

    CAS  PubMed  Google Scholar 

  47. Miller ME, Thorpe SL, Dores GM (1995) Influence of hormones on platelet intracellular calcium. Thromb Res 77:515–530

    Article  CAS  PubMed  Google Scholar 

  48. Anwaar I, Rendell M, Gottsater A, Lindgarde F, Hulthen UL, Mattiasson I (2000) Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin. J Intern Med 247:463–470

    Article  CAS  PubMed  Google Scholar 

  49. Reineri S, Bertoni A, Sanna E et al (2007) Membrane lipid rafts coordinate estrogen-dependent signaling in human platelets. Biochim Biophys Acta 1773:273–278

    Article  CAS  PubMed  Google Scholar 

  50. Moro L, Reineri S, Piranda D et al (2005) Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. Blood 105:115–121

    Article  CAS  PubMed  Google Scholar 

  51. Carrer HF, Cambiasso MJ, Gorosito S (2005) Effects of estrogen on neuronal growth and differentiation. J Steroid Biochem Mol Biol 93:319–323

    Article  CAS  PubMed  Google Scholar 

  52. Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62:155–198

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Srivastava DP, Waters EM, Mermelstein PG, Kramar EA, Shors TJ, Liu F (2011) Rapid estrogen signaling in the brain: implications for the fine-tuning of neuronal circuitry. J Neurosci 31:16056–16063

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Wu TW, Wang JM, Chen S, Brinton RD (2005) 17Beta-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135:59–72

    Article  CAS  PubMed  Google Scholar 

  55. Zhao L, Brinton RD (2007) Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 1172:48–59

    Article  CAS  PubMed  Google Scholar 

  56. Alkayed NJ, Goto S, Sugo N et al (2001) Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci 21:7543–7550

    CAS  PubMed  Google Scholar 

  57. Yang LC, Zhang QG, Zhou CF et al (2010) Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One 5:e9851

    Article  PubMed Central  PubMed  Google Scholar 

  58. Marin R, Ramirez CM, Gonzalez M, Alonso R, Diaz M (2006) Alternative estrogen receptors homologous to classical receptor alpha in murine neural tissues. Neurosci Lett 395:7–11

    Article  CAS  PubMed  Google Scholar 

  59. Deecher DC, Swiggard P, Frail DE, O’Connor LT (2003) Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine 22:211–223

    Article  CAS  PubMed  Google Scholar 

  60. Ramirez CM, Gonzalez M, Diaz M et al (2009) VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer’s disease. Mol Cell Neurosci 42:172–183

    Article  CAS  Google Scholar 

  61. Meitzen J, Mermelstein PG (2011) Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J Chem Neuroanat 42:236–241

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Akanda N, Tofighi R, Brask J, Tamm C, Elinder F, Ceccatelli S (2008) Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells. Cell Cycle 7:3225–3234

    Article  CAS  PubMed  Google Scholar 

  63. Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R (2011) Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer’s disease. J Neurochem 116:820–827

    Article  CAS  PubMed  Google Scholar 

  64. Garcia-Segura LM, Sanz A, Mendez P (2006) Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84:275–279

    Article  CAS  PubMed  Google Scholar 

  65. Garcia-Segura LM, Arevalo MA, Azcoitia I (2010) Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog Brain Res 181:251–272

    Article  CAS  PubMed  Google Scholar 

  66. Marin R, Diaz M, Alonso R, Sanz A, Arevalo MA, Garcia-Segura LM (2009) Role of estrogen receptor alpha in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor. J Steroid Biochem Mol Biol 114:2–7

    Article  CAS  PubMed  Google Scholar 

  67. Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423

    Article  CAS  PubMed  Google Scholar 

  68. Pernis AB (2007) Estrogen and CD4 + T cells. Curr Opin Rheumatol 19:414–420

    Article  CAS  Google Scholar 

  69. Karpuzoglu E, Zouali M (2011) The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol 40:16–26

    Article  CAS  PubMed  Google Scholar 

  70. Cunningham M, Gilkeson G (2011) Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 40:66–73

    Article  CAS  PubMed  Google Scholar 

  71. Giovannetti A, Pierdominici M, Di Iorio A et al (2008) Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des 14:253–268

    Article  CAS  PubMed  Google Scholar 

  72. Phiel KL, Henderson RA, Adelman SJ, Elloso MM (2005) Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 97:107–113

    Article  CAS  PubMed  Google Scholar 

  73. Tubiana N, Mishal Z, le Caer F et al (1986) Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry. Br J Cancer 54:501–504

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Adori M, Kiss E, Barad Z et al (2010) Estrogen augments the T cell-dependent but not the T-independent immune response. Cell Mol Life Sci 67:1661–1674

    Article  CAS  PubMed  Google Scholar 

  75. Benten WP, Stephan C, Wunderlich F (2002) B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 67:647–654

    Article  CAS  PubMed  Google Scholar 

  76. Benten WP, Lieberherr M, Giese G, Wunderlich F (1998) Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 422:349–353

    Article  CAS  PubMed  Google Scholar 

  77. Pierdominici M, Maselli A, Colasanti T et al (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132:79–85

    Article  CAS  PubMed  Google Scholar 

  78. Colasanti T, Maselli A, Conti F et al (2012) Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 64:778–787

    Article  CAS  PubMed  Google Scholar 

  79. Schneider AE, Karpati E, Schuszter K et al (2014) A dynamic network of estrogen receptors in murine lymphocytes: fine-tuning the immune response. J Leukoc Biol 96:857–872

    Article  CAS  PubMed  Google Scholar 

  80. Pietras RJ, Marquez-Garban DC (2007) Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res 13:4672–4676

    Article  CAS  PubMed  Google Scholar 

  81. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  82. Pietras RJ, Arboleda J, Reese DM et al (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435–2446

    CAS  PubMed  Google Scholar 

  83. Osborne CK, Bardou V, Hopp TA et al (2003) Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95:353–361

    Article  CAS  PubMed  Google Scholar 

  84. Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ (2006) Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 246:91–100

    Article  CAS  PubMed  Google Scholar 

  85. Engelman JA, Lee RJ, Karnezis A et al (1998) Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 273:20448–20455

    Article  CAS  PubMed  Google Scholar 

  86. Font de Mora J, Brown M (2000) AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041–5047

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  87. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER (2002) Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768–50775

    Article  CAS  PubMed  Google Scholar 

  88. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39

    Article  CAS  PubMed  Google Scholar 

  89. Sorice M, Manganelli V, Matarrese P et al (2009) Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett 583:2447–2450

    Article  CAS  PubMed  Google Scholar 

  90. Yang SH, Liu R, Perez EJ et al (2004) Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA 101:4130–4135

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Ortona.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maselli, A., Pierdominici, M., Vitale, C. et al. Membrane lipid rafts and estrogenic signalling: a functional role in the modulation of cell homeostasis. Apoptosis 20, 671–678 (2015). https://doi.org/10.1007/s10495-015-1093-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-015-1093-5

Keywords

Navigation